Medi-Tech Insights Get in touch

Global GLP-1 Analogues Market Size & Trends Report Segmented by Product (Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda), Route of Administration (Subcutaneous, Oral), Application (Diabetes, Obesity), End-user Analysis & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • GLP-1 Analogues Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising prevalence of type 2 diabetes and obesity
          • Expanding pharmaceutical R&D pipelines and innovative GLP-1 combinations
          • Increasing adoption for chronic weight management among non-diabetic populations
          • Growing healthcare spending on chronic disease management
          • Rising awareness of metabolic health and preventive care
        • Restraints
          • High therapy cost and complex manufacturing requirements
          • Strict regulatory requirements
          • Limited reimbursement policy
        • Opportunities
          • Development of dual or multi-agonist therapies
          • Expansion into adolescent obesity and pediatric diabetes treatment
          • Adoption of oral GLP-1 analogues improving patient convenience
          • Rising demand in emerging markets with high metabolic disease burden
        • Key Market Trends
          • Growing for cardiovascular and renal risk reduction
          • Increased integration of digital tools for adherence and remote monitoring
        • Unmet Market Needs
        • Industry Speaks
      • "5">
    • Global GLP-1 Analogues Market Size & Forecast (2024-2031), By Product, USD Million
      • Introduction
      • Ozempic
      • Trulicity
      • Mounjaro
      • Wegovy
      • Rybelsus
      • Saxenda
      • Others
  • Global GLP-1 Analogues Market Size & Forecast (2024-2031), By Route of Administration, USD Million
    • Introduction
    • Subcutaneous
    • Oral
  • Global GLP-1 Analogues Market Size & Forecast (2024-2031), By Application, USD Million
    • Introduction
    • Diabetes
    • Obesity
    • Others
  • Global GLP-1 Analogues Market Size & Forecast (2024-2031), By End-user, USD Million
    • Introduction
    • Hospitals
    • Specialty Clinics
    • Homecare Settings
    • Others
    1. Global GLP-1 Analogues Market Size & Forecast (2024-2031), By Region, USD Million
      • Introduction
      • North America GLP-1 Analogues Market Size & Forecast (2024-2031), By Country, USD Million
        • US
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Route of Administration (USD Million)
          • Market Size & Forecast, By Application (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Canada
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Route of Administration (USD Million)
          • Market Size & Forecast, By Application (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
      • Europe GLP-1 Analogues Market Size & Forecast (2024-2031), By Country, USD Million
        • UK g i>Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Germany
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • France
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Italy
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Spain
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
    2. Asia Pacific (APAC) GLP-1 Analogues Market Size & Forecast (2024-2031), By Country, USD Million
      • China
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Mill (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Japan
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • India
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Route of Administration (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Fore>Latin America (LATAM) GLP-1 Analogues Market Size & Forecast (2024-2031), USD Million
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Route of Administration (USD Million)
          • Market Size & Forecast, By Application (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Middle East & Africa (MEA) GLP-1 Analogues Market Size & Forecast (2024-2031), USD Million
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Route of Administration (USD Million)
          • Market Size & Forecast, By Application (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
            • "10">
          • Competitive Landscape
            • Key Players and their Competitive Positioning
              • Key Player Comparison
              • Segment-wise Player Mapping
              • Market Share Analysis (2025)
              • Company Categorization Matrix
                • Dominants/Leaders
                • New Entrants
                • Emerging Players
                • Innovative Players
              • Key Strategies Assessment, By Player (2023-2025)
                • New Product Launches
                • Partnerships, Agreements, & Collaborations
                • Mergers & Acquisitions
                • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • Eli Lilly and Company
    • Novo Nordisk A/S
    • Inc
    • AstraZeneca PLC
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Limited
    • Boehringer Ingelheim International GmbH
    • PegBio Co., Ltd.
    • Innovent Biologics, Inc.
    • Amgen Inc.
    • Other Prominent Players

    Note: *Indicative list

    **For listed companies

    Related Reports

    View All Research Reports